EMEA gives go-ahead to first advanced therapy
This article was originally published in RAJ Devices
Executive Summary
A cell-based medicine for repairing knee damage has become the first product to be recommended for approval by the European Medicines Agency under the European Union’s new advanced therapy regulatory framework1.
You may also be interested in...
Pharma Guidelines, ending 1 July 2011
Recently updated and newly issued documents
EuropaBio appoints new chairman
EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.
Medtech Guidelines, ending 24 June 2011
Recently updated and newly issued documents